
Industrials · Building Products
$130.09
-3.54%
Vol: 809K
Wednesday, June 17, 2026
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
No material news in the last 48 hours.
Allegion reported Q1 2026 EPS of $1.80, missing the $1.89 consensus, on revenue of $1.03B (up 9.7% YoY, in line). The stock dropped roughly 5.66% in pre-market reaction. The company reaffirmed 2026 guidance of 6%-8% reported revenue growth (including the DCI acquisition), 2%-4% organic growth, and adjusted EPS of $8.70-$8.90. Allegion returned cash to shareholders with $47M in dividends and $40M in buybacks during the quarter, and authorized a new $500M repurchase program. Net debt was 1.7x adjusted EBITDA. Boston Partners disclosed 4.26M shares in an amended 13G filing. Allegion also earned the Gallup Exceptional Workplace Award for the third consecutive year.
No material news in the last 48 hours.
Boston Partners disclosed beneficial ownership of 4,260,020 Allegion shares (4.95% of common stock) as of March 31, 2026 in an amended Schedule 13G/A filed on May 14, 2026. Allegion shares eased to around $131.30 on May 12, marking a third consecutive daily loss. Q1 2026 results showed revenue of $1.03 billion (up 9.7% YoY) but EPS of $1.80 missed the $1.89 consensus by 4.76%. The company reaffirmed its full-year 2026 outlook of 6%-8% reported revenue growth, 2%-4% organic growth and adjusted EPS of $8.70-$8.90. Shares trade between a 52-week range of $134.67 to $183.11.
Allegion reported Q1 2026 EPS of $1.80, missing estimates of $1.89 by 4.76%, while revenue rose 9.7% YoY to $1.03 billion, narrowly beating expectations. Shares dropped 6.7% following the earnings report and are down 16.6% year-to-date. Senior VP and Chief Innovation and Design Officer Robert C. Martens sold 3,993 shares of stock in a transaction valued at $547,639 on May 11, 2026. Barclays reduced its price target from $165 to $161 while maintaining an Equalweight rating. Analyst consensus price target stands at $168 despite the recent EPS miss and operating income shortfall. The stock recently hit a 52-week low at $131.16.
Allegion stock hit a 52-week low of $131.16 following Q1 2026 results on April 28 that missed EPS expectations at $1.80 vs $1.89 forecast, though revenue met expectations at $1.03B (up 9.7% YoY). On May 7, 2026, SVP-Chief Innovation & Design Robert C. Martens sold 3,993 ordinary shares at $137.15 per share in an open-market transaction. Shares fell 6.7% to $137 in the week after earnings. The 2026 revenue outlook was raised to 6-8% solely to reflect the DCI Hollow Metal acquisition, while organic growth targets remain unchanged. CEO John H. Stone cited strong Q1 revenue growth led by Americas non-residential and electronics businesses. Analyst consensus price target sits at $168 implying ~22% upside. Risk centers on persistent EPS pressure and weak residential market conditions.
No material news in the last 48 hours.
No material news in the last 48 hours.
Allegion reported Q1 2026 net revenues of $1.03B with 9.7% YoY growth, beating estimates by 0.8%, but non-GAAP EPS of $1.80 missed the $1.89 consensus by 4.76% and shares fell 6.7% post-earnings. Management attributed results to strong nonresidential demand in Americas and recent acquisitions, but organic growth was hurt by ERP system disruptions in a legacy international business causing production inefficiencies and lower margins. The company guided 2026 revenue growth of 5-7% and adjusted EPS of $8.70-$8.90. Allegion received the Gallup Exceptional Workplace Award for the third consecutive year. Consensus analyst PT is $168, vs current price around $132.52.
Allegion reported Q1 2026 net revenues of $1,033.6M (+9.7% YoY) and adjusted EPS of $1.80, down 3.2% YoY due to nearly 200 basis points of operating margin contraction. GAAP EPS declined 7%. Stock hit 52-week low of $134.45, down 18% over 6 months. Multiple analysts reduced targets: BofA to $150 from $157, JPMorgan to $170 from $180, Baird to $165 from $190, Barclays to $161 from $165. Stock declined 6.7% post-earnings.
| Company | Price | Day | 1M | Fwd P/E | Beta | Mkt Cap |
|---|---|---|---|---|---|---|
| TTTRANE | $473.17 | -0.46% | +2.6% | 27.8x | 1.21 | $104.5B |
| JCIJOHNSON | $144.06 | -0.76% | +4.6% | 24.9x | 1.34 | $87.6B |
| CARRCARRIER | $69.72 | -2.02% | +7.7% | 21.7x | 1.34 | $57.7B |
| LIILENNOX | $516.04 | -2.33% | +2.9% | 19.3x | 1.19 | $18.0B |
| MASMASCO | $72.98 | -2.43% | +10.8% | 15.4x | 1.31 | $14.6B |
| ALLEALLEGION | $130.09 | -3.54% | +1.3% | 13.6x | 0.88 | $11.2B |
Price below 200d MA — bearish structure.